Medidata Blog

See you at 2018 ASCO? Let’s Talk Genomics Data and Analysis in Oncology Research

Reading Time: 2 minutes

Going to the 2018 ASCO Annual Meeting this year? The Industry Expert Theater (IET) at ASCO brings together industry leaders and attendees interested in the latest drug development research. I hope to see you at 9:30am on June 2 in the Oncology Professionals Hall at McCormick Place, because we are very excited to talk about how genomic data is being integrated into clinical trials—sometimes not so successfully, and sometimes very, very successfully.

Biomarkers, including genomic biomarkers, improve the likelihood of clinical trial success. We know genomic data can drive treatment decisions in clinical studies, but it’s becoming apparent that many researchers lack secure technology infrastructure to integrate genomic data with other clinical data.

Medidata Solutions is hosting a presentation* to discuss these issues with Dr. Jason Mezey, principal researcher for Rave Omics at Medidata Solutions and professor at Cornell University/Weill Cornell Medical College, Dr. Ruthanna Davi, senior director of data science at Medidata and former deputy director of biometrics at FDA, and Dr. Ana Oromendia, business analytics manager for omics at Medidata.

These three experts will discuss omics, biomarker discovery and the role machine learning and automated statistical methodology play in clinical development.

Streamline data capture, link genomic analysis within a clinical study, and shorten drug development timelines—that’s the promise we see with new technology like Medidata Rave Omics with Biomarker Discovery. The panel will highlight recent genomic biomarkers discoveries with the application of Rave Omics in various clinical trials.

See you there?

Presentation Title: Integration of Genomics Data and Analysis in Oncology Research

Date and Time: 9:30 AM–10:30 AM Central Time, Saturday, June 2, 2018

Location: Oncology Professionals Hall at McCormick Place Convention Center in Chicago


*Not an official presentation of the 2018 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation. Not CME-accredited.

Jacob Angevine